Adding Radiotherapy to Adjuvant Chemotherapy Improves OS in Stage IV Endometrial Cancer
The greatest benefit was observed when chemotherapy was combined with external beam radiation therapy and vaginal brachytherapy.
Diagnosis & Disease Information
Treatment Duration and Interval of Bortezomib, Lenalidomide for MM Predictive of Skin Rash
A retrospective review sought to better understand the relationship between bortezomib and lenalidomide therapy and treatment-induced skin rash in multiple myeloma.
MIBC Tumor Subtypes May Guide Neoadjuvant Chemotherapy Use
Neoadjuvant chemotherapy response rates differed among patients with genomically unstable bladder tumors, urothelial-like bladder tumors, and basal/squamous subtypes.
Bladder Cancer Progression Despite BCG Therapy Predicts Worse Outcomes
Progression on bacillus Calmette-Guérin (BCG) likely represents a biologically aggressive disease state as well as diagnostic delay, according to investigators.
Neoadjuvant Chemo May Improve Outcomes for MIBC of Variant Histology
Findings refute the notion that variant histology MIBC will not respond to neoadjuvant chemotherapy.
Real-World Data Support Same-Day Pegfilgrastim Prophylaxis to Reduce Febrile Neutropenia Risk
Investigators sought to determine if same-day administration of prophylactic pegfilgrastim was as effective as next-day administration.
Survey Reveals Oncologists’ Preferences Regarding Scalp Cooling Therapy
Researchers identified patterns around usage of scalp cooling therapy to reduce the risk of chemotherapy-induced alopecia in patients.
First-Line Immunotherapy, Chemotherapy for mUC of the Bladder Offer Similar Survival
Real-world data validate recently reported findings from clinical trials.
Study Supports Low-Dose Dexamethasone as Premedication for Taxanes
There was no significant difference in the risk of hypersensitivity reactions with low-dose or high-dose dexamethasone.
Large PICC Size May Up Risk for Thrombosis in Cancer Patients
Risk for thrombosis doubled if catheter-to-vein ratio exceeds 45 percent for peripherally inserted central catheter.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...